EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting ICAM1 to Ameliorate Vaso‐Occlusion and Inflammation in Sickle Cell Disease

Parul Gupta, Ravindra Kumar

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Parul Gupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Disorders, ICMR-National Institute of Research in Tribal Health, Jabalpur, India. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Intercellular Adhesion Molecule-1, Inflammation, Molecular Targeted Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: ICMR, New Delhi, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is a hereditary disorder characterized by vaso‐occlusion, inflammation, and tissue damage. Intercellular adhesion molecule 1 (ICAM‐1) plays a crucial role in the pathophysiology of SCD by promoting the adhesion of sickle cells to the endothelium, contributing to vaso‐occlusion and tissue damage. The ICAM‐1 gene encodes a glycoprotein that interacts with lymphocyte function–associated antigen 1 (LFA‐1) and macrophage 1‐antigen (Mac‐1) receptors, perpetuating inflammation, and oxidative stress. The NF‐κB signaling pathway regulates ICAM‐1 expression, which is elevated in patients with SCD, leading to increased endothelial cell activation and damage. Targeting ICAM‐1 and its interactions with sickle cells and the endothelium has emerged as a potential therapeutic strategy for managing SCD. This review highlights the complex interplay between ICAM‐1, sickle cells, and the endothelium, and discusses the potential of ICAM‐1‐targeted therapies for mitigating VOC and improving the quality of life for patients with SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellIntercellular Adhesion Molecule-1InflammationMolecular Targeted TherapyHumansAnimalsSignal TransductionEndothelium, VascularDisease ManagementDisease SusceptibilityVascular Diseases

Stichwörter der Autor:innen

ICAM‐1endotheliuminhibitorsickle cell diseasevaso‐occlusive crisis

Substanzen

Intercellular Adhesion Molecule-1ICAM1 protein, human

Autor:innen und Institutionen

  • Division of Genetic Disorders, ICMR-National Institute of Research in Tribal Health, Jabalpur, India.

Förderung

  • ICMR, New Delhi
  • Indian Council of Medical Research

Zitieren

APA

Gupta, P., & Kumar, R. (2024). Targeting ICAM1 to Ameliorate Vaso‐Occlusion and Inflammation in Sickle Cell Disease. European Journal of Haematology. https://doi.org/10.1111/ejh.14313

Vancouver

Gupta P, Kumar R. Targeting ICAM1 to Ameliorate Vaso‐Occlusion and Inflammation in Sickle Cell Disease. European Journal of Haematology. 2024. doi:10.1111/ejh.14313

BibTeX
@article{Gupta2024,
  author = {Gupta, Parul and Kumar, Ravindra},
  title = {Targeting ICAM1 to Ameliorate Vaso‐Occlusion and Inflammation in Sickle Cell Disease},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14313}
}
Kostenlos starten →